African American and older patients with pancreatic cancer are less likely to receive pancreatic enzyme replacement therapy, which may help prevent malnutrition, morbidity and mortality, according to a study led by C. Roberto Simons-Linares, MD, MSc of Cleveland Clinic and presented at ACG's 2020 Annual Virtual Scientific Meeting. PERT was prescribed more often in patients with chronic pancreatitis, malnutrition, bariatric surgery and vitamin D deficiency.
Study: African American, older adults less likely to get PERT
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.